T1	Participants 56 87	anemia of chronic renal disease
T2	Participants 191 225	iron-replete hemodialysis patients
T3	Participants 337 364	4 androgen-treated patients
T4	Participants 1015 1037	three control subjects
T5	Participants 1729 1758	chronic hemodialysis patients
